Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Acurx Pharmaceuticals Inc market cap is $6.3M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Acurx Pharmaceuticals Inc 52 week high is $7.54 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Acurx Pharmaceuticals Inc 52 week low is $0.90 as of November 22, 2026.
Acurx Pharmaceuticals Inc stock price today is $1.04.
Acurx Pharmaceuticals Inc stock price yesterday was $1.03.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Acurx Pharmaceuticals Inc's P/E ratio is -0.45.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Acurx Pharmaceuticals Inc P/B ratio is 0.8326.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Acurx Pharmaceuticals Inc 50-day moving average is $1.17.